Medicure (MCUJF) Accounts Payables (2009 - 2026)
Medicure's (MCUJF) quarterly Accounts Payables came in at $7.2 million in Q1 2026, up 23.01% year-on-year from $5.8 million in Q1 2025, and down 5.75% quarter-over-quarter from $7.6 million in Q4 2025.
Medicure (MCUJF) Accounts Payables (2009 - 2026) Analysis & Trends
Medicure's Accounts Payables history runs 18 years deep, the most recent figure standing at $7.2 million for Q1 2026.
- On a quarterly basis, Accounts Payables rose 23.01% year-over-year to $7.2 million in Q1 2026; TTM through Mar 2026 was $7.2 million, a 23.01% increase from a year earlier, with the FY2025 full-year figure at $7.6 million, up 30.79% from the prior year.
- Accounts Payables slipped to $7.2 million in Q1 2026 per MCUJF's latest filing, from $7.6 million in the prior quarter.
- Across five years, Accounts Payables topped out at $7.6 million in Q4 2025 and bottomed at $4.2 million in Q3 2023.
- The 5-year median for Accounts Payables is $5.7 million (2024), against an average of $5.7 million.
- Across the five-year window, Accounts Payables soared 1554.79% in 2022 and decreased 12.98% in 2023, its largest moves.
- Year by year, Accounts Payables stood at $5.3 million in 2022, then climbed by 6.35% to $5.6 million in 2023, then gained by 1.67% to $5.7 million in 2024, then surged by 33.7% to $7.6 million in 2025, then declined by 5.75% to $7.2 million in 2026.
- Per Business Quant, the three latest MCUJF Accounts Payables figures stand at $7.2 million (Q1 2026), $7.6 million (Q4 2025), and $5.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | 7.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.15 Mn |
| Dec 31, 2025 | 7.59 Mn |
| Sep 30, 2025 | 5.74 Mn |
| Jun 30, 2025 | 6.17 Mn |
| Mar 31, 2025 | 5.82 Mn |
| Dec 31, 2024 | 5.68 Mn |
| Sep 30, 2024 | 5.55 Mn |
| Jun 30, 2024 | 6.01 Mn |
| Mar 31, 2024 | 5.70 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Sep 30, 2023 | 4.23 Mn |
| Mar 31, 2023 | 4.77 Mn |
| Dec 31, 2022 | 5.25 Mn |
| Sep 30, 2022 | 4.86 Mn |
| Jun 30, 2022 | 6.51 Mn |
| Mar 31, 2022 | 4.98 Mn |
| Dec 31, 2021 | 317,334.43 |
| Sep 30, 2021 | 4.91 Mn |
| Jun 30, 2021 | 5.56 Mn |
| Mar 31, 2021 | 5.13 Mn |